Published on in Vol 9, No 12 (2020): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23830, first published .
Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

Junko Terada-Hirashima   1 , MPH, MD ;   Manabu Suzuki   1 , MD ;   Yukari Uemura   2 , PhD ;   Masayuki Hojo   1 , MD, PhD ;   Ayako Mikami   2 , MD, PhD ;   Wataru Sugiura   2 , MD, PhD ;   Norio Ohmagari   3 , MD, PhD ;   Haruhito Sugiyama   1 , MD, PhD

1 Department of Pulmonary Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan

2 Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

3 Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan

Corresponding Author:

  • Junko Terada-Hirashima, MPH, MD
  • Department of Pulmonary Medicine
  • Center Hospital of the National Center for Global Health and Medicine
  • 1-21-1 Toyama Shinjuku-ku
  • Tokyo
  • Japan
  • Phone: 81 332027181
  • Email: jterada@hosp.ncgm.go.jp